Moderna, Inc., has announced its Singapore subsidiary with a new leadership announcement. 

Evelyn Pang has been appointed the General Manager of Moderna Singapore with her nearing two decades of spectacular role around vaccines and specialty care therapeutics. Moderna's Singapore presence will be built by Pang, who will establish a team to oversee commercial and medical activities. 

“We are delighted to have Evelyn lead our activities in Singapore. With Evelyn’s diverse experience and extensive unique network within the Asia-Pacific healthcare ecosystem, there will be countless opportunities for building our business under her leadership in Singapore,” said Patrick Bergstedt, Senior Vice President – Head Emerging Markets, Moderna. 

In the Asia-Pacific region, Moderna has a commercial presence in Australia, Hong Kong, Japan, South Korea, Singapore, and Taiwan, with plans to also establish a commercial presence in Malaysia.